← All indications
Infant, Premature, Diseases
Diseases that occur in PREMATURE INFANTS.
Subtype terms (4)
More specific conditions that are subtypes of Infant, Premature, Diseases in the MeSH hierarchy.
- Bronchopulmonary Dysplasia
72 drugs (41 approved, 31 experimental)
- Leukomalacia, Periventricular
14 drugs (11 approved, 3 experimental)
- Respiratory Distress Syndrome, Newborn
26 drugs (18 approved, 8 experimental)
- Retinopathy of Prematurity
47 drugs (29 approved, 18 experimental)
Drugs by status
Approved for this indication (1)
Phase 4 trials (28)
- iron
- betamethasone
- egg
- folic acid
- soybean oil
- amoxicillin
- meningococcal (groups A, C, Y, W) CRM197 conjugate vaccine
- human milk
- cow milk
- pneumococcal 13-valent conjugate vaccine
- poractant alfa
- caffeine
- surfactant
- hepatitis b vaccine (recombinant)
- red blood cells
- lactoferrin
- beractant
- clonidine
- sulfadoxine
- azithromycin
- budesonide
- clindamycin
- pyrimethamine
- acellular pertussis vaccine (including diptheria and tetanus toxoids)
- iron sulfate
- meningococcal (group B) vaccine
- ampicillin
- Inactivated polio virus - Enhanced
Phase 3 trials (22)
Phase 2 trials (19)
Organizations
Organization Involved with Phase 4 Indications (4)
Organization Involved with Phase 3 Indications (6)
Organization Involved with Phase 2 Indications (2)
Organization Involved with Other Experimental Indications (9)